Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Pharmacology and Experimental Therapeutics|June 16, 2011
Combining small interfering RNAs targeting thymidylate synthase and thymidine kinase 1 or 2 sensitizes human tumor cells to 5-fluorodeoxyuridine and pemetrexedC Di Cresce, R Figueredo, P J Ferguson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2012
Development and validation of a prediction index for hand-foot skin reaction in cancer patients receiving sorafenibG Dranitsaris, M D Vincent, J Yu, et al.
British Journal of Pharmacology|September 14, 1999
Antisense down-regulation of thymidylate synthase to suppress growth and enhance cytotoxicity of 5-FUdR, 5-FU and Tomudex in HeLa cellsP J Ferguson, O Collins, N M Dean, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1987
Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancerI E Smith, B D Evans, M E Gore, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1997
Superior vena cava obstruction in small-cell lung cancerR H Chan, A R Dar, E Yu, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1986
An analysis of possible prognostic features of long term and short term survivors of metastatic breast cancerM D Vincent, T J Powles, R Skeet, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
The modulating effects of flurbiprofen on adriamycin plus vincristine or vindesine in the treatment of advanced breast cancerD J Perez, T J Powles, I E Smith, et al.
Oncology Reports|October 14, 1998
In vitro carboplatin-mesna interaction in aqueous solution, human plasma and urineM M Obrocea, M A Nassim, M J Molepo, et al.
Lung Cancer (Amsterdam, Netherlands)|September 12, 2001
Using treatment interruptions to palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer decreases survival and disease controlG M Videtic, K Fung, A T Tomiak, et al.
Current Oncology (Toronto, Ont.)|June 20, 2007
Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced DiarrheaJ A Maroun, L B Anthony, N Blais, et al.
Pageof 3